These insights could lay the foundation for exploring a specific understanding of the cellular contexts that dictate the phenotypic output of DDR2 regulation and for uncovering critical metabolic targets that mediate the protumorigenic effects of DDR2 in cancer cells. The gene discussed is DDR2; the disease is cancer.